Clinical Trials Sponsored by Altavant Sciences, Inc.

Total 1407 results

Power Life Sciences Inc.

Not yet recruiting

Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients

Glioblastoma
Power Life Sciences Inc.

Not yet recruiting

Investigating the Experiences of Individuals With Gastric Cancer Participating in Clinical Trials

Gastric Cancer
Power Life Sciences Inc.

Not yet recruiting

Evaluation of the Patient's Experience in Medical Studies for Cholangiocarcinoma

Cholangiocarcinoma
Power Life Sciences Inc.

Not yet recruiting

Examining the Experiences of Brain Injury Patients in Medical Trials

Brain Injuries
TransThera Sciences (Nanjing), Inc.

Recruiting

A Phase 1 Study to Evaluate the Safety and Tolerability of TT-01488 in Patients With B-Cell Malignancies

B-Cell Malignancies

China
Kezar Life Sciences, Inc.

Recruiting

A Study of Zetomipzomib (KZR-616) in Patients With Autoimmune Hepatitis (PORTOLA)

Autoimmune Hepatitis

United States
Power Life Sciences Inc.

Not yet recruiting

Evaluating Clinical Trial Experiences of Individuals With Congestive Heart Failure

Congestive Heart Failure
Power Life Sciences Inc.

Not yet recruiting

Investigating The Experiences of Patients In Immunotherapy Clinical Trials

Cancer | Immunotherapy
Power Life Sciences Inc.

Not yet recruiting

Analyzing Clinical Trial Experiences of Prostate Cancer Patients

Prostate Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Medical Trial: Appraising Medical Trial Experiences of Rheumatoid Arthritis Patients

Rheumatoid Arthritis

United States
TransThera Sciences (Nanjing), Inc.

Recruiting

To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors

Gastric Cancer | Prostate Cancer | Cholangiocarcinoma | Bladder Cancer | Triple Negative Breast Cancer | Advanced Solid Tumor | Small-cell Lung Cancer | Thyroid Cancer | Biliary Tract Cancer | Gallbladder Cancer | HER2-negative Breast Cancer

China
TransThera Sciences (Nanjing), Inc.

Completed

Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma

Cholangiocarcinoma | FGFR2 Gene Mutation | FGFR2 Fusion | FGFR1 Alteration | FGFR3 Alteration

United States
TransThera Sciences (Nanjing), Inc.

Available

Rollover Study to Provide Continued Access to TT-00420 (Tinengotinib) for Subjects With Advanced Solid Tumors

Advanced Solid Tumors | Cholangiocarcinoma

United States
TriSalus Life Sciences, Inc.

Active, not recruiting

Intrahepatic Delivery of SD-101 by Pressure-Enabled Regional Immuno-oncology (PERIO), With Checkpoint Blockade in Adults With Metastatic Uveal Melanoma

Metastatic Uveal Melanoma in the Liver

United States
Surgical Information Sciences Inc.

Completed

Accuracy Evaluation of SIS Software-based Visualization of New Anatomical Brain Structure

Software Evaluation for Visualizing Anatomical Structures Not Typically Identified on Clinical MR Images

United States
TransThera Sciences (Nanjing), Inc.

Completed

A Phase 1 Study of TT-00920 in Healthy Subjects

Healthy

China
TransThera Sciences (Nanjing), Inc.

Completed

Phase I, First-In-Human Study of TT-00920 in Healthy Subjects

Healthy

United States
Surgical Information Sciences Inc.

Terminated

SIS Evaluation of the MRI Defined Subthalamic Nucleus* (STN)

Deep Brain Stimulation

United States
Kezar Life Sciences, Inc.

Withdrawn

A Phase 2 Study to Evaluate the Safety and Efficacy of KZR-616 in Patients With AIHA and ITP (MARINA)

Immune Thrombocytopenia | Autoimmune Hemolytic Anemia

Poland, United States, Australia, Italy, Russian Federation
EtectRX, Inc.
Quotient Sciences

Completed

Performance of the ID-Cap System, an Ingestion Event Marker, in the Clinical Setting as an Aid to Measure Medication Adherence

Healthy Volunteers

United States
Celtaxsys, Inc.
Quotient Sciences

Completed

Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-Acebilustat (CTX-4430)

Heathy Volunteers

United Kingdom
Bioniche Life Sciences Inc.

Completed

Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer

Bladder Neoplasms

Canada, United States
Telomerase Activation Sciences, Inc

Unknown

Effect of TA-65MD on Healthy Volunteers (TA-65MD)

Healthy

United States
Human Genome Sciences Inc.

Completed

A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer

United States, Germany, Hungary, Romania
Human Genome Sciences Inc.

Completed

Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE)

Lupus Erythematosus, Systemic

United States, Canada
Human Genome Sciences Inc.

Completed

Safety and Efficacy of an Antibody to CCR5 in Individuals With HIV Who Are Not Currently on Antiretroviral Therapy

HIV Infections

United States
Human Genome Sciences Inc.

Completed

Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus

United States
Oculus Innovative Sciences, Inc.

Completed

Pilot Study of the Safety and Clinical Efficacy of Topical Dermacyn™ Wound Care to Treat Mild Diabetic Foot Infections

Foot Ulcer, Diabetic

United States
ReAlta Life Sciences, Inc.

Not yet recruiting

Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refractory Acute Graft-versus-Host Disease (AURORA)

Steroid Refractory GVHD
Power Life Sciences Inc.

Not yet recruiting

Examining Engagement Trends Among Participants in Peripheral Neuropathy Clinical Research

Peripheral Neuropathy

United States
Power Life Sciences Inc.

Not yet recruiting

Assessing Patient Engagement in Keratoconus Clinical Research

Keratoconus

United States
Power Life Sciences Inc.

Not yet recruiting

Delving Into Participation Trends of Scleroderma Clinical Trials

Scleroderma

United States
Power Life Sciences Inc.

Not yet recruiting

Studying Patterns in Patient Engagement Among Tardive Dyskinesia Patients

Tardive Dyskinesia

United States
Power Life Sciences Inc.

Not yet recruiting

Exploring Clinical Study Experiences of People With Anorexia Nervosa

Anorexia Nervosa

United States
Power Life Sciences Inc.

Not yet recruiting

Revealing Engagement Patterns Among Hepatic Encephalopathy Patients

Hepatic Encephalopathy

United States
Power Life Sciences Inc.

Not yet recruiting

Evaluating the Occurrence of Participation Trends Among Weight Loss Clinical Trials Patients

Weight Loss

United States
Power Life Sciences Inc.

Not yet recruiting

Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients

Recurrent Prostate Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Insights Into Participating in Studies for Bone Cancer

Bone Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Investigating Participation Patterns Among Recurrent Ovarian Cancer Patients

Recurrent Ovarian Cancer

United States
TransThera Sciences (Nanjing), Inc.

Recruiting

Study of TT-00420 (Tinengotinib) in Subjects With Cholangiocarcinoma Who Failed or Relapsed to Chemotherapy and FGFR Inhibitor

Cholangiocarcinoma Metastatic

China
Power Life Sciences Inc.

Not yet recruiting

Investigating Engagement Patterns and Participation Trends Among Liposarcoma Patients

Liposarcoma

United States
Power Life Sciences Inc.

Not yet recruiting

Understanding Engagement Trends in Chondrosarcoma Clinical Trials

Chondrosarcoma

United States
Power Life Sciences Inc.

Not yet recruiting

Delving Into Participation Patterns in Social Anxiety Studies

Social Anxiety

United States
Power Life Sciences Inc.

Not yet recruiting

Revealing Engagement Patterns Among Endometrial Cancer Patients

Endometrial Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Insights Into Participating in Studies for Uterine Cancer

Uterine Cancer

United States
Power Life Sciences Inc.

Not yet recruiting

Delving Into Borderline Personality Disorder Clinical Trial Experiences

Borderline Personality Disorder

United States
Power Life Sciences Inc.

Not yet recruiting

Evaluation of Study Experiences of Neuroendocrine Tumor Patients

Neuroendocrine Tumors

United States
Power Life Sciences Inc.

Not yet recruiting

Navigating the Clinical Research Process for Glioma

Glioma

United States
Power Life Sciences Inc.

Not yet recruiting

Evaluating Factors In Study Experiences of Lymphedema Patients

Lymphedema

United States
Power Life Sciences Inc.

Not yet recruiting

Assessment of Schizophrenia Patients' Clinical Study Experiences

Schizophrenia

United States

Clinical Trials Sponsored by Altavant Sciences, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations